Showing 1 posts of 1 posts found.
Roche’s next-generation breast cancer drug T-DM1 has impressed at the European cancer congress after besting Herceptin in a new study. …
Most advanced breast cancer patients treated in community settings, Phesi study finds
Orforglipron shows weight and glucose advantages over oral semaglutide in indirect comparison
Bramacare opens supported-living facility for eating disorder recovery
Aiforia deal to expand access to pathology AI
SMC accepts atogepant for acute migraine treatment in Scotland